Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hormone
Research
Veru touts novel breast cancer treatment strategy
Veru aims to launch a phase 3 study of its androgen receptor agonist enobosarm in heavily pretreated ER-positive/HER2-negative breast cancer.
Angus Liu
Jan 21, 2021 7:31am
BridgeBio's en route to proving out its 'Moneyball' model: CEO
Sep 29, 2020 7:00am
Spruce scores phase 2a win for rare disease drug, preps for 2020
Sep 19, 2019 8:00am
A new approach to resistant prostate cancer
Aug 29, 2019 9:00am
Could the 'hunger hormone' boost memory?
Jul 10, 2019 10:20am
New insight into melatonin could lead to better sleep drugs
Apr 25, 2019 12:58pm
